- Home
- / Hanmi Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hanmi Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩332 K
2024-10-29
Market Capitalization
₩4.2 T
2024-10-29
Revenue
₩1.5 T
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.0T | 1.1T | 1.1T | 1.2T | 1.3T | 1.5T | 1.5T | 1.5T |
| Cost of goods sold | 273.7B | 257.0B | 266.2B | 312.6B | 330.0B | 563.2B | 581.1B | 564.3B |
| Gross profit | 749.1B | 868.7B | 814.0B | 893.5B | 1.0T | 936.0B | 921.3B | 991.0B |
| Gross profit margin, % | 73.7% | 78.0% | 75.7% | 74.3% | 75.7% | 62.8% | 61.6% | 64.0% |
| Operating expense total | 611.5B | 697.4B | 699.3B | 674.9B | 746.7B | 608.6B | 600.9B | 626.6B |
| Depreciation and amortization | 55.2B | 59.1B | 60.9B | 89.6B | 100.6B | 107.6B | 97.2B | 101.8B |
| EBITDA | 137.6B | 171.4B | 114.7B | 218.6B | 252.6B | 328.7B | 320.4B | 364.4B |
| EBITDA margin, % | 13.5% | 15.4% | 10.7% | 18.2% | 19.0% | 22.0% | 21.4% | 23.5% |
| EBIT | 67.1B | 107.0B | 46.0B | 112.3B | 137.9B | 212.3B | 183.1B | 216.8B |
| EBIT margin, % | 6.6% | 9.6% | 4.3% | 9.3% | 10.4% | 14.2% | 12.2% | 14.0% |
| Interest income | 4.3B | 4.4B | 4.4B | 5.7B | 7.9B | 4.6B | 5.7B | 7.3B |
| Interest expense | 19.4B | 25.0B | 24.9B | 16.6B | 22.6B | 28.5B | 24.4B | 17.0B |
| Pre tax profit | 50.4B | 83.3B | 22.1B | 103.7B | 121.0B | 194.0B | 171.3B | 213.5B |
| Income tax expense | 16.2B | 19.4B | 4.8B | 22.2B | 19.5B | 28.6B | 30.8B | 26.3B |
| Net Income | 34.2B | 63.9B | 17.3B | 81.5B | 101.6B | 165.4B | 140.4B | 187.1B |